strongyloidiasis (Strongyloides stercoralis)
Advices
Priority | Medication | Remarks |
---|---|---|
Priority: 1st choice |
Medication: ivermectine po 0.2mg/kg 1dd 2 days |
Remarks:
Therapie herhalen na 2 weken |
Priority: 2nd choice |
Medication: albendazol po 400mg 2dd 7 days |
Sources
-
Pubmed.gov publication # 23394259
Buonfrate D, Requena-Mendez A, Angheben A, Muñoz J, Gobbi F, Van Den Ende J, Bisoffi Z (2013) Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis. 13:78
-
Pubmed.gov publication # 22691685
Mejia R, Nutman TB (2012) Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis. 25(4):458-63
-
Pubmed.gov publication # 23900531
Greaves D., Coggle S., Pollard C., Aliyu S.H., Moore EM (2013) Strongyloides stercoralis infection. BMJ 30;347:f4610.
-
Pubmed.gov publication # 21349223
Keiser J, Ingram K, Utzinger J. (2011) Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control. Parasitology 138:1620-32
Antimicrobial resources
The following antimicrobial agents have been used in these recommendations:
External antimicrobial resources
Menu position
Metadata
Swab vid: G-148259.6
Updated: 01/19/2024 - 15:50
Status: Published
General comments
Hyperinfectie
Ivermectine:
Albendazol:
Controle op eradicatie na behandeling is aanbevolen:
Screening bij langdurige immuunsuppressie